1. A requirement of serotonergic p38α mitogen-activated protein kinase for peripheral immune system activation of CNS serotonin uptake and serotonin-linked behaviors. Baganz NL, Lindler KM, Zhu CB, Smith JT, Robson MJ, Iwamoto H, Deneris ES, Hewlett WA, Blakely RD (2015) Transl Psychiatry : e671
    › Primary publication · 26529424 (PubMed) · PMC5068761 (PubMed Central)
  2. 3D visualization of the regional differences. Ellegood J, Anagnostou E, Babineau BA, Crawley JN, Lin L, Genestine M, DiCicco-Bloom E, Lai JK, Foster JA, Peñagarikano O, Geschwind DH, Pacey LK, Hampson DR, Laliberté CL, Mills AA, Tam E, Osborne LR, Kouser M, Espinosa-Becerra F, Xuan Z, Powell CM, Raznahan A, Robins DM, Nakai N, Nakatani J, Takumi T, van Eede MC, Kerr TM, Muller C, Blakely RD, Veenstra-VanderWeele J, Henkelman RM, Lerch JP (2015) Mol Psychiatry 20(1): 1
    › Primary publication · 25648202 (PubMed) · PMC5131793 (PubMed Central)
  3. Transgenic overexpression of the presynaptic choline transporter elevates acetylcholine levels and augments motor endurance. Holmstrand EC, Lund D, Cherian AK, Wright J, Martin RF, Ennis EA, Stanwood GD, Sarter M, Blakely RD (2014) Neurochem Int : 217-28
    › Primary publication · 24274995 (PubMed) · PMC4104494 (PubMed Central)
  4. The SLC6 transporters: perspectives on structure, functions, regulation, and models for transporter dysfunction. Rudnick G, Krämer R, Blakely RD, Murphy DL, Verrey F (2014) Pflugers Arch 466(1): 25-42
    › Primary publication · 24337881 (PubMed) · PMC3930102 (PubMed Central)
  5. The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants. Mergy MA, Gowrishankar R, Gresch PJ, Gantz SC, Williams J, Davis GL, Wheeler CA, Stanwood GD, Hahn MK, Blakely RD (2014) Proc Natl Acad Sci U S A 111(44): E4779-88
    › Primary publication · 25331903 (PubMed) · PMC4226116 (PubMed Central)
  6. The brain in flux: genetic, physiologic, and therapeutic perspectives on transporters in the CNS. Blakely RD, Ortega A, Robinson MB (2014) Neurochem Int : 1-3
    › Primary publication · 24751395 (PubMed)
  7. SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking. Bowton E, Saunders C, Reddy IA, Campbell NG, Hamilton PJ, Henry LK, Coon H, Sakrikar D, Veenstra-VanderWeele JM, Blakely RD, Sutcliffe J, Matthies HJ, Erreger K, Galli A (2014) Transl Psychiatry : e464
    › Primary publication · 25313507 (PubMed) · PMC4350523 (PubMed Central)
  8. Quantitative trait loci mapping and gene network analysis implicate protocadherin-15 as a determinant of brain serotonin transporter expression. Ye R, Carneiro AM, Han Q, Airey D, Sanders-Bush E, Zhang B, Lu L, Williams R, Blakely RD (2014) Genes Brain Behav 13(3): 261-75
    › Primary publication · 24405699 (PubMed) · PMC4436591 (PubMed Central)
  9. Good riddance to dopamine: roles for the dopamine transporter in synaptic function and dopamine-associated brain disorders. Gowrishankar R, Hahn MK, Blakely RD (2014) Neurochem Int : 42-8
    › Primary publication · 24231471 (PubMed)
  10. Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder. Mergy MA, Gowrishankar R, Davis GL, Jessen TN, Wright J, Stanwood GD, Hahn MK, Blakely RD (2014) Neurochem Int : 56-70
    › Primary publication · 24332984 (PubMed) · PMC4177817 (PubMed Central)